E. Davis - Feb 24, 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
EVP-Gen. Diagnostics/CEO Elect
Signature
/s/ William J. O'Shaughnessy, Jr., attorney-in-fact for James E. Davis
Stock symbol
DGX
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 06:48 PM
Previous filing
Feb 25, 2022
Next filing
Mar 9, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Award $0 +9.79K +20.61% $0.00 57.3K Feb 24, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Non-Qualifed Stock Option (right to buy) Award $0 +47.5K $0.00 47.5K Feb 24, 2022 Common Stock 47.5K $127.73 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted share units.
F2 The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.